Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
3
100%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 23 (100.0%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_2

A Clinical Study of 6MW3211 in Patients With Renal Cancer

NCT05440045
unknownphase_2

A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma

NCT05446688
unknownphase_2

A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer

NCT05431569

Clinical Trials (3)

Showing 3 of 3 trials
NCT05440045Phase 2

A Clinical Study of 6MW3211 in Patients With Renal Cancer

Unknown
NCT05446688Phase 2

A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma

Unknown
NCT05431569Phase 2

A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3